CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 133 enrolled
Drug / intervention
50ug selenium enriched yeast +5 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00279812
NCT00279812N/ACompleted

Selenium and Immune Function

Quadram Institute Bioscience·interventional·Posted Jan 20, 2006·Updated Jul 16, 2018

In Brief

A clinical study evaluating 50ug selenium enriched yeast, 100ug selenium enriched yeast, and 4 other interventions for Healthy. Completed, enrolled 133 participants across 1 site.

Detailed Summary

The aim of the study is to investigate the relationship between dose and form of selenium on immune function, and to identify functional markers of selenium status.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 20, 2006
Enrollment StartApr 1, 2005
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 20.4 years ago

Interventions

50ug selenium enriched yeastdietary

Selenomethionine supplement (50ug/d Se) for 12 weeks

100ug selenium enriched yeastdietary

Selenomethionine supplement (100ug/d Se) for 12 weeks

200ug selenium enriched yeastdietary

Selenomethionine supplement (200ug/d Se) for 12 weeks

Control oniondietary

3 meals per week containing un-enriched onion (4ug/d) for 12 weeks

Enriched oniondietary

3 meals per week containing un-enriched onion (50ug/d) for 12 weeks

Placeboother

Placebo supplement for 12 weeks